@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_head { this: np:hasAssertion dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_assertion; np:hasProvenance dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_provenance; np:hasPublicationInfo dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_publicationInfo; a np:Nanopublication . dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_assertion a np:Assertion . dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_provenance a np:Provenance . dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_publicationInfo a np:PublicationInfo . } dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_assertion { miriam-gene:60 a ncit:C16612 . lld:C0010068 a ncit:C7057 . dgn-gda:DGN911b8fb4cf5c5cc9c88432862d90acac sio:SIO_000628 miriam-gene:60, lld:C0010068; a sio:SIO_001121 . } dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_provenance { dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_assertion dcterms:description "[We investigated mRNA expression levels using reverse transcription-polymerase chain reaction of genes involved in cholesterol uptake (macrophage scavenger receptor (MSR1), scavenger receptor class B member 1 (SRB1), lectin-like oxidized low-density lipoprotein (LDL) receptor 1 (LOX1), CD36, LDL receptor (LDLR)), reverse cholesterol transport (apolipoprotein E (ApoE), ATP-binding cassette sub-family A member 1 (ABCA1)) and inflammation (tumour necrosis factor-alpha (TNF-alpha), macrophage inflammatory protein-1alpha (MIP-1alpha), interleukin-6 (IL-6), tissue factor) in CD14(+) monocytes from 119 consecutively recruited patients and found that median CD36 mRNA expression levels were significantly increased in patients with CHD compared with controls (111 x 10(3) vs 96 x 10(3) copies/10(6) copies beta-actin, respectively; n = 79 and 40, respectively; P < 0.05), despite a high interindividual variability in gene expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:18067591; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP221617.RA_1lZtIFzNhdi0f3niZ3lZYJ27ZDFT1yy5uLT-85Z150130_publicationInfo { this: dcterms:created "2015-08-25T14:39:46+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }